Codiak BioSciences, Inc.
EXTRACELLULAR VESICLES TARGETING T CELLS AND USES THEREOF
Last updated:
Abstract:
The present disclosure relates to modified extracellular vesicles, e.g, exosomes, comprising a targeting moiety (e.g., anti-CD3 targeting moiety), wherein the targeting moiety can specifically bind to markers expressed on distinct immune cells (e.g., T cells). Also provided herein are methods for using the exosomes to treat and/or prevent a range of medical disorders.
Status:
Application
Type:
Utility
Filling date:
2 Jul 2020
Issue date:
11 Aug 2022